en · de · es · pt
thymosin-alpha-1-notes.peptides1004.com › Wiki › Molecular Background And Identity — Practical Notes

Molecular Background And Identity — Practical Notes

By Editorial Desk · published 2026-02-16 · last reviewed 2026-03-13 · Wiki

The short version of lyophilized powder fits in a sentence. The long version — which is the one that helps — is below.

Reviewed 2026-03-13. Anything still debated is marked as such rather than presented as settled.

Molecular Background and Identity

Clinical interest has centered on chronic viral hepatitis, on immune restoration in various conditions, and on use as an adjuvant intended to improve responses to vaccines. Trials have reported mixed results, and regulatory status differs sharply between countries; in some places it is a prescription product, while elsewhere it is sold without an approved therapeutic indication. Because published studies vary widely in design, population, and endpoints, comparisons across them are difficult and no single conclusion covers the whole literature.

Thymosin alpha 1 is a short peptide of 28 amino acid residues that derives from the amino terminal region of a larger precursor protein known as prothymosin alpha. The peptide carries an acetyl group on its first residue and contains no disulfide bonds or carbohydrate chains. Its sequence is highly conserved across mammalian species, which is one reason laboratories treat it as a molecule with a defined and reproducible structure rather than a variable tissue extract. The name follows an early naming convention for thymus-derived fractions and does not imply that the peptide acts as a hormone in the classical endocrine sense.

Biologically, the peptide is studied mainly in the context of immune cell development and regulation. It is produced in the thymus and in several other tissues, and it appears to influence the maturation and activity of T cells and other immune populations. Laboratory work describes effects on cytokine production, on the balance between T cell subsets, and on the function of dendritic cells. Much of this evidence comes from cell culture and animal models, so the extent to which the same pathways operate in humans remains an open question.

免疫调节机制与信号

在信号层面,Tα1可能通过Toll样受体等模式识别受体发挥作用。部分实验显示,它能激活髓样分化因子88依赖的通路,进而促进核因子κB进入细胞核。这导致白细胞介素2、干扰素γ和白细胞介素12等细胞因子的转录增加。这些细胞因子偏向辅助性T细胞1型应答,有助于细胞免疫。然而,具体受体和结合位点尚未完全确定,不同实验模型的结果存在差异。

临床研究将Tα1用于慢性病毒感染、肿瘤辅助治疗和疫苗佐剂等场景。部分试验报告了免疫学指标改善,但临床终点获益在不同研究中并不一致。系统综述指出,研究间在人群、剂量和联合方案上差异较大,难以汇总结论。因此,Tα1的确切临床地位仍属开放问题,需要更多高质量随机对照试验来澄清。其机制研究也需从体外实验向体内模型推进。

胸腺素α1对免疫系统的影响涉及多种细胞类型。研究表明,它可促进未成熟T细胞向成熟T细胞分化,并增强T细胞对抗原刺激的增殖反应。树突状细胞在Tα1存在下表达更高水平的共刺激分子,从而更有效地呈递抗原。此外,自然杀伤细胞的活性也观察到上升。这些效应并非直接杀伤病原体,而是调节宿主免疫应答的强度与方向。

Thymosin-alpha-1 at a glance

PropertyValueNotes
Molecular massApproximately 3,108 DaConsistent with a 28-residue acetylated peptide
Residue count28Corresponds to the amino terminal region of prothymosin alpha
Appearance of dry powderWhite to off-white solidSlight variation between lots is normal
Solubility classFreely soluble in waterLow solubility in most organic solvents
Common synonymsThymosin alpha 1, T alpha 1The numeral reflects an early fraction numbering scheme

分子身份与天然来源

市售的胸腺素α1通常以冻干粉形式提供,溶解后用于注射。其氨基酸组成包括多个酸性残基,因此在中性pH下带负电荷。该肽可溶于水和生理盐水,但在有机溶剂中溶解度有限。储存条件通常为冻干状态下负20摄氏度,溶解后需冷藏并避免反复冻融。常见的同义词包括胸腺肽α1、thymalfasin和Tα1。

胸腺素α1(thymosin alpha 1,Tα1)是一种由28个氨基酸组成的酸性肽,N端被乙酰化,分子量约为3108道尔顿。该肽最早从牛胸腺组织提取物中分离,属于胸腺素组分5的一个成分。其序列在不同哺乳动物中高度保守,提示其具有基本的生物学功能。名称中的“α1”指其在电泳中的迁移位置,并非表示亚型编号。它既存在于胸腺,也存在于脾脏和淋巴结等免疫组织。

Related pages on this site

Storage, Handling, and Analytical Methods

Identity and purity are normally confirmed by reversed-phase high-performance liquid chromatography and mass spectrometry. The expected mass for the acetylated 28-residue peptide is close to 3108 daltons, and a mass shift indicates a modification or truncation. Peptide mapping after enzymatic digestion can resolve sequence-level questions. Counter-ion content, water content, and residual solvents are separate quality attributes that a certificate of analysis may or may not report. Aggregation is monitored by size-exclusion chromatography when relevant.

Thymosin alpha-1 is supplied as a lyophilized powder in most research settings. The solid dissolves readily in water and in common aqueous buffers, and it is typically reconstituted shortly before use. Solutions are clear and colourless at ordinary working concentrations. Because the peptide is hygroscopic, weighing and reconstitution are usually performed with minimal exposure to ambient air. Aliquots are prepared to avoid repeated freeze-thaw cycles, and working solutions are kept cold.

Background, Structure, and Mechanism

Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Results across trials have been mixed, and several studies were small or conducted under differing protocols. Regulatory status varies by country, and the compound is not approved in every jurisdiction where it is studied. Evidence for any single indication should be read with attention to sample size and endpoint choice.

Thymosin alpha-1 is a 28-residue peptide first isolated from thymus tissue in the 1970s. It corresponds to the N-terminal portion of thymosin beta-4, from which it is cleaved in vivo. The peptide carries an acetyl group at its N-terminus, a modification that affects its charge and stability. Synthetic material produced by solid-phase peptide synthesis is chemically identical to the natural fragment and is the form used in research and clinical studies.

Laboratory work indicates that the peptide acts on cells of both the innate and adaptive immune systems. Reported effects include signalling through Toll-like receptors on dendritic cells, enhanced T-cell maturation, and increased natural killer cell activity. These actions are described largely from cell-culture and animal experiments, and the precise receptor-level events remain incompletely defined. Studies in humans have generally measured immune markers rather than a single defined molecular target. The resulting picture remains partly descriptive.

Analytical Methods and Storage Stability

Quality control for thymosin alpha-1 focuses on identity, purity, and potency. Identity is confirmed by mass spectrometry and amino acid analysis, while purity is assessed by chromatography with limits on related substances and residual solvents. Potency assays may use cell-based immune readouts, but these are not standardized across laboratories. Regulatory status differs by jurisdiction; no product is approved in the United States for clinical use, whereas some other countries register injectable forms for specific indications.

Quantifying thymosin alpha-1 in a sample usually relies on reverse-phase high-performance liquid chromatography. The peptide lacks strong chromophores, so detection often occurs at 214 nm, where the peptide backbone absorbs. Mass spectrometry provides confirmatory identification and can detect sequence variants or truncations. Immunoassays have been used in biological matrices, but they may cross-react with related fragments. For purity assessment, chromatographic peak area gives the main component percentage, while mass accuracy verifies molecular identity.

The lyophilized peptide is generally stable for extended periods when kept cold and dry. Once dissolved, aqueous solutions are less stable; hydrolysis, oxidation, and aggregation can degrade the material. Storage at -20 °C or lower slows these processes. Repeated freeze-thaw cycles are best avoided because they can promote aggregation. The exact shelf life depends on formulation, pH, and concentration, so stability studies are typically performed for each specific product.

Background from the literature

== Drawbacks == Acromegaly patients, who suffer from natural growth hormone levels of up to 100 times higher than normal, have lower stamina towards physical activity than people with regular levels. When the patients are treated and their growth hormone levels decrease, their stamina improves. This knowledge is part of the evidence behind the new belief that athletes who use supplemental HGH to raise their levels far above average could actually decrease their exercise tolerance, and thus hurt their athletic performance. Further backing was provided in a study done by the Danish Institute of Sports Medicine. They found cyclists of good health and endurance "were unable to complete accustomed cycling tasks after administration of exogenous hGH" and concluded that HGH can inhibit recuperation from exercise. Participants have also been found to have lower stamina after HGH treatment along with higher rates of fatigue. Although adverse side effects can result from excessive doses, typical GH therapy has few side effects and those have likely been overstated due to the excessive amounts administered in earlier studies.

=== Centrally-projecting neurons === As well as neuroendocrine neurons, the PVN contains interneurons and populations of neurons that project centrally (i.e., to other brain regions). The centrally-projecting neurons include

== Etymology == It is named for the English physician and anatomist Thomas Wharton (1614–1673) who first described it in his publication Adenographia, or "The Description of the Glands of the Entire Body", first published in 1656.

=== West Asia === In Saudi Arabia, about 4.2% of the population carries the sickle cell trait, and 0.26% have sickle cell disease. The highest prevalence is in the Eastern province, where approximately 17% of the population carries the gene and 1.2% have sickle cell disease. In 2005, Saudi Arabia introduced a mandatory premarital test including HB electrophoresis, which aimed to decrease the incidence of sickle cell disease and thalassemia. In Bahrain, a study published in 1998 that covered about 56,000 people in hospitals in Bahrain found that 2% of newborns have sickle cell disease, 18% of the surveyed people have the sickle cell trait, and 24% were carriers of the gene mutation causing the disease. The country began screening of all pregnant women in 1992, and newborns started being tested if the mother was a carrier. In 2004, a law was passed requiring couples planning to marry to undergo free premarital counselling. These programmes were accompanied by public education campaigns.

Sources: en.wikipedia.org

Reference notes

While the BPC was primarily political, Black Consciousness activists also established the Black Community Programmes (BCPs) to focus on improving healthcare and education and fostering black economic self-reliance. The BCPs had strong ecumenical links, being part-funded by a program on Christian action, established by the Christian Institute of Southern Africa and the South African Council of Churches. Additional funds came from the Anglo-American Corporation, the International University Exchange Fund, and Scandinavian churches. In 1972, the BCP hired Biko and Bokwe Mafuna, allowing Biko to continue his political and community work. In September 1972, Biko visited Kimberley, where he met the PAC founder and anti-apartheid activist Robert Sobukwe. Biko's banning order in 1973 prevented him from working officially for the BCPs from which he had previously earned a small stipend, but he helped to set up a new BPC branch in Ginsberg, which held its first meeting in the church of a sympathetic white clergyman, David Russell. Establishing a more permanent headquarters in Leopold Street, the branch served as a base from which to form new BCPs; these included self-help schemes such as classes in literacy, dressmaking and health education. For Biko, community development was part of the process of infusing black people with a sense of pride and dignity. Near King William's Town, a BCP Zanempilo Clinic was established to serve as a healthcare centre catering for rural black people who would not otherwise have access to hospital facilities.

Notably, yeast incorporates more mannose molecules during N-glycosylation when compared with other eukaryotes, which may trigger cellular conformational stress responses. Such responses may result in failure in reaching native protein conformation, implying potential reduction of serum half-life and immunogenicity. Regarding application, both the hepatitis B virus surface antigen (HBsAg) and the virus-like particles (VLPs) of the major capsid protein L1 of human papillomavirus type 6, 11, 16, 18 are produced by Saccharomyces cerevisiae.

On April 25, 2023, President Joe Biden officially announced his re-election campaign, confirming that Vice President Kamala Harris would remain his running mate. Concerns about Biden's age were prominent, given that he was the oldest person to assume the office at age 78, which would make him 82 at the end of his first term and 86 at the end of a potential second term. An April 2023 poll indicated that 70 percent of Americans, including 51 percent of Democrats, believed Biden should not seek a second term, with nearly half citing his age as the reason. Biden's approval rating stood at 41 percent, with 55 percent disapproving. Speculation also arose that Biden might face a primary challenge from the Democratic Party's progressive faction; however, after Democrats outperformed expectations in the 2022 midterm elections, many believed Biden's chances of securing the party's nomination had increased. On July 28, 2022, Representative Dean Phillips of Minnesota became the first incumbent Democratic member of Congress to say Biden should not run for re-election and called for "generational change", pointing to Biden's age. Despite a handful of primary challengers, including Representative Dean Phillips, Robert F. Kennedy Jr., Marianne Williamson, and Jason Palmer, Biden easily became the party's presumptive nominee on March 12, 2024. Palmer, who won the American Samoa caucuses, became the first candidate to win a contested primary against an incumbent president since Ted Kennedy in 1980.

In enzymology, a 3-hydroxyisobutyrate dehydrogenase (EC 1.1.1.31) also known as β-hydroxyisobutyrate dehydrogenase or 3-hydroxyisobutyrate dehydrogenase, mitochondrial (HIBADH) is an enzyme that in humans is encoded by the HIBADH gene. 3-Hydroxyisobutyrate dehydrogenase catalyzes the chemical reaction:

Supratrochlear nerve and the supraorbital nerve from the ophthalmic division of the trigeminal nerve Greater occipital nerve (C2) posteriorly up to the vertex Lesser occipital nerve (C2) behind the ear Zygomaticotemporal nerve from the maxillary division of the trigeminal nerve supplying the hairless temple Auriculotemporal nerve from the mandibular division of the trigeminal nerve The innervation of scalp can be remembered using the mnemonic 'Z-GLASS' for Zygomaticotemporal nerve, Greater occipital nerve, Lesser occipital nerve, Auriculotemporal nerve, Supratrochlear nerve, and Supraorbital nerve. The motor innervation of the scalp, specifically, the occipitofrontalis muscle, is split into two main factions: the frontal belly or frontalis muscle is supplied by the temporal branch of facial nerve, while the occipital belly or occipitalis is supplied by the posterior auricular branch of facial nerve.

Sources: en.wikipedia.org

Notes from published material

== Function == The protein encoded by this gene is a cytoplasmic enzyme involved in cellular energy homeostasis. The encoded protein reversibly catalyzes the transfer of "energy-rich" phosphate between ATP and creatine and between phosphocreatine and ADP. Its functional entity is a MM-CK homodimer in striated (sarcomeric) skeletal and cardiac muscle.

33,000, 25 October 2017 - The SENSEX closed at 33,042.50, for its first close above the 33,000 level. 34,000, 26 December 2017 - The SENSEX closed at 34,010.62, for its first close above the 34,000 level. 35,000, 17 January 2018 - The SENSEX closed at 35,081.82, for its first close above the 35,000 level. 36,000, 23 January 2018 - The SENSEX closed at 36,139.98, for its first close above the 36,000 level. 37,000, 27 July 2018 - The SENSEX on 26 July 2018 crossed the 37,000 mark for the first time during intra-day trading. On 27 July 2018 the index closed above the milestone. 38,000, 9 August 2018 - For the first time SENSEX passed the score of 38,000 during intra-day trading, and then closed at 38,024.37. 39,000, 1 April 2019 – The SENSEX on 1 April 2019 crossed the 39,000 mark for the first time during intra-day trading. 2 April 2019 – The SENSEX closed at 39,056.65, for its first close above the 39,000 level. 40,000, 23 May 2019 – The SENSEX crossed "40,000.100" at 10:45 AM for the first time. (2019 Loksabha (House of the People) Election results were getting published) 41,000, 26 November 2019 – The SENSEX crossed "41,120.28" first time during intraday trading. 42,000, 16 January 2020 - The SENSEX crossed 42,000 mark with an all-time high of 42,059.45 at around 09:47 AM. 45,000, 4 December 2020 - The SENSEX crossed 45,000 mark with an all-time high of 45,033 at around 10:30 AM. 46,000, 9 December 2020 - The SENSEX crossed 46,000 mark with an all-time high of 46,017 at around 1:30 PM.

== Expression and regulation == Metallothionein gene expression is induced by a high variety of stimuli, as metal exposure, oxidative stress, glucocorticoids, vitamin D, hydric stress, fasting, exercise, etc. Beta-hydroxylbutyration of histone proteins upregulates MT2. The level of the response to these inducers depends on the MT gene. MT genes present in their promoters specific sequences for the regulation of the expression, elements as metal response elements (MRE), glucocorticoid response elements (GRE), GC-rich boxes, basal level elements (BLE), and thyroid response elements (TRE).

=== United Kingdom === Rhodesia was originally a self-governing British crown colony. Although decolonisation in Africa had begun after World War II, it began accelerating in the early 1960s, causing Britain to negotiate independence rapidly with several of its colonies. During this period, it adopted a foreign policy called NIBMAR, or No Independence Before Majority African Rule, mandating democratic reforms that placed governance in the hands of the majority black Africans. The governing white minority of Rhodesia, led by Ian Smith, opposed the policy and its implications. On 11 November 1965, Rhodesia's minority white government made a unilateral declaration of independence (UDI) from the United Kingdom, as it became apparent that negotiations would not lead to independence under the white regime. The United Kingdom government immediately brought in legislation (Southern Rhodesia Act 1965) which formally abolished all Rhodesian government institutions. This move made life difficult for Rhodesian citizens who wished to travel internationally as passports issued by Rhodesia's UDI administration were not recognised as valid; in January 1966, the British issued a statement accepting as valid any passport issued before the declaration of independence and allowing six-month United Kingdom passports to be granted when they expired – provided that the bearer declared they did not intend to aid the UDI Rhodesian government.

==== MeSH D12.776.964.775.325 – gene products, env (gene) ==== MeSH D12.776.964.775.325.330 – hiv envelope protein gp41 MeSH D12.776.964.775.325.350 – hiv envelope protein gp120 MeSH D12.776.964.775.325.380 – hiv envelope protein gp160

Sources: en.wikipedia.org

Frequently asked questions

Is thymosin alpha 1 a hormone?

The name reflects an early convention for naming thymus-derived fractions. The peptide is characterized and measured as a defined molecule, and it does not operate through a single classical endocrine axis.

胸腺素α1如何影响T细胞?

它促进未成熟T细胞分化并增强成熟T细胞的增殖与细胞因子分泌。这些作用有助于放大抗原特异性免疫应答。

它是否通过特定受体起作用?

目前认为它可能通过Toll样受体等模式识别受体传递信号,但精确的受体身份和结合机制尚未完全阐明。

为什么临床证据不一致?

不同试验在患者选择、给药方案、联合治疗和终点定义上差异很大。这些异质性使得跨研究比较困难,结论难以统一。

Network